Tetrahydrocannabivarin

CAS: 31262-37-0

Ref. TM-TN5131

Información del producto

• Nombre: Tetrahydrocannabivarin
• Sinónimos: THCV, delta9-Tetrahydrocannabivarin, CRM, Tetrahydrocannavarin, (-)-Δ⁹-trans-Tetrahydrocannabivarin, (6AR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol, (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo[b,d]pyran-1-ol, 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR-trans)-, 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (-)-, 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR,10aR)-, Cannabidivarol, Δ¹-tetrahydro-, Cannabivarol, Δ⁹-tetrahydro-, O 4394, Tetrahydrocannabinol-C3, Thc-C3, Thc-V, n-Propyl-Δ⁹-tetrahydrocannabinol, Δ¹-Tetrahydrocannabidivarol, Δ⁹-Tetrahydrocannabivarin, Δ⁹-Tetrahydrocannabivarol, Cannabidivarol, Δ1-tetrahydro-

Descripción

Tetrahydrocannabivarin (CRM) is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, this effect profile suggests therapeutic activity in obesity, perhaps with a lowered risk of depressive side effects. Tetrahydrocannabivarin exhibits anticonvulsant effects in a piriform cortical brain slice model of epileptiform activity.

• Marca: Targetmol

Propiedades químicas

• Peso molecular: 286.41
• Fórmula: C₁₉H₂₆O₂
• Pureza: 96.30%
• Color/Forma: Solid